NewslettersCell Therapy News LILRB1-Directed CAR-T Cells for the Treatment of Hematological Malignancies By Noshin Noorjahan - April 7, 2025 0 1548 Researchers observed stable LILRB1 expression in B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma, even after CD20/CD19-based immunotherapies. [Leukemia] Full Article